Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.
J Thromb Haemost. 2018 Jan;16(1):150-163. doi: 10.1111/jth.13901. Epub 2017 Nov 28.
Essentials Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP). Obese ADAMTS-13-deficient mice were triggered with von Willebrand factor (VWF). Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model. VWF enhances phagocytosis of platelets by macrophages, dose-dependently.
Background Thrombotic thrombocytopenic purpura (TTP) is caused by the absence of ADAMTS-13 activity. Thrombocytopenia is presumably related to the formation of microthrombi rich in von Willebrand factor (VWF) and platelets. Obesity may be a risk factor for TTP; it is associated with abundance of macrophages that may phagocytose platelets. Objectives To evaluate the role of obesity and ADAMTS-13 deficiency in TTP, and to establish whether macrophages contribute to thrombocytopenia. Methods Lean or obese ADAMTS-13-deficient (Adamts-13 ) and wild-type (WT) mice were injected with 250 U kg of recombinant human VWF (rVWF), and TTP characteristics were evaluated 24 h later. In separate experiments, macrophages were depleted in the liver and spleen of lean and obese WT or Adamts-13 mice by injection of clodronate-liposomes, 48 h before injection of rVWF. Results Obese Adamts-13 mice had a lower platelet count than their lean counterparts, suggesting that they might be more susceptible to TTP development. Lean Adamts-13 mice triggered with a threshold dose of rVWF did not develop TTP, whereas typical TTP symptoms developed in obese Adamts-13 mice, including severe thrombocytopenia and higher lactate dehydrogenase (LDH) levels. Removal of hepatic and splenic macrophages by clodronate injection in obese Adamts-13 mice before treatment with rVWF preserved the platelet counts measured 24 h after the trigger. In vitro experiments with cultured macrophages confirmed a VWF dose-dependent increase of platelet phagocytosis. Conclusions Obese Adamts-13 mice are more susceptible to the induction of TTP-related thrombocytopenia than lean mice. Phagocytosis of platelets by macrophages contributes to thrombocytopenia after rVWF injection in this model.
肥胖是血栓性血小板减少性紫癜(TTP)发展的潜在危险因素。肥胖的 ADAMTS-13 缺乏症小鼠用血管性血友病因子(VWF)触发。肝和脾巨噬细胞耗竭可防止该模型中的血小板减少症。VWF 剂量依赖性地增强巨噬细胞对血小板的吞噬作用。
背景血栓性血小板减少性紫癜(TTP)是由 ADAMTS-13 活性缺失引起的。血小板减少症推测与富含血管性血友病因子(VWF)和血小板的微血栓形成有关。肥胖可能是 TTP 的一个危险因素;它与可能吞噬血小板的巨噬细胞的丰度有关。目的评估肥胖和 ADAMTS-13 缺乏症在 TTP 中的作用,并确定巨噬细胞是否有助于血小板减少症。方法将瘦或肥胖的 ADAMTS-13 缺陷(Adamts-13 )和野生型(WT)小鼠注射 250 U kg 重组人 VWF(rVWF),并在 24 小时后评估 TTP 特征。在单独的实验中,通过注射氯膦酸盐脂质体在瘦或肥胖的 WT 或 Adamts-13 小鼠的肝和脾中耗竭巨噬细胞,在注射 rVWF 前 48 小时。结果肥胖的 Adamts-13 小鼠的血小板计数低于其瘦对应物,表明它们可能更容易发生 TTP 发展。瘦的 Adamts-13 小鼠用阈值剂量的 rVWF 触发不会发展为 TTP,而肥胖的 Adamts-13 小鼠则出现典型的 TTP 症状,包括严重的血小板减少症和更高的乳酸脱氢酶(LDH)水平。在 rVWF 治疗前用氯膦酸盐注射清除肥胖的 Adamts-13 小鼠的肝和脾巨噬细胞可维持触发后 24 小时测量的血小板计数。与培养的巨噬细胞进行的体外实验证实了 VWF 剂量依赖性增加血小板吞噬作用。结论肥胖的 Adamts-13 小鼠比瘦小鼠更容易发生与 TTP 相关的血小板减少症。在该模型中,rVWF 注射后,巨噬细胞对血小板的吞噬作用导致血小板减少症。